The effect of ionizing radiation on regulatory T cells in health and disease

Cancer Letters
Eszter PersaKatalin Lumniczky

Abstract

Treg cells are key elements of the immune system which are responsible for the immune suppressive phenotype of cancer patients. Interaction of Treg cells with conventional anticancer therapies might fundamentally influence cancer therapy response rates. Radiotherapy, apart from its direct tumor cell killing potential, has a contradictory effect on the antitumor immune response: it augments certain immune parameters, while it depresses others. Treg cells are intrinsically radioresistant due to reduced apoptosis and increased proliferation, which leads to their systemic and/or intratumoral enrichment. While physiologically Treg suppression is not enhanced by irradiation, this is not the case in a tumorous environment, where Tregs acquire a highly suppressive phenotype, which is further increased by radiotherapy. This is the reason why the interest for combined radiotherapy and immunotherapy approaches focusing on the abrogation of Treg suppression has increased in cancer therapy in the last few years. Here we summarize the basic mechanisms of Treg radiation response both in healthy and cancerous environments and discuss Treg-targeted pre-clinical and clinical immunotherapy approaches used in combination with radiotherapy. Finally...Continue Reading

References

Feb 1, 1994·The Journal of Clinical Investigation·M H Barcellos-HoffJ A Weatherbee
Oct 23, 1997·Current Opinion in Cell Biology·F G Giancotti
Aug 26, 1998·Proceedings of the National Academy of Sciences of the United States of America·A A HurwitzJ P Allison
Jul 12, 2001·The Journal of Biological Chemistry·N S SampsonP Gotwals
Oct 7, 2004·International Immunology·Haruhiko YagiShimon Sakaguchi
Oct 19, 2005·The Journal of Experimental Medicine·François GhiringhelliLaurence Zitvogel
Nov 1, 2005·Molecular Therapy : the Journal of the American Society of Gene Therapy·Sonja Van MeirvenneKris Thielemans
Dec 6, 2005·Cancer Immunology, Immunotherapy : CII·Koji KonoHideki Fujii
Sep 12, 2006·International Journal of Oncology·Meora FeinmesserBritta Hardy
Feb 23, 2007·International Journal of Cancer. Journal International Du Cancer·Oliver M GrauerGosse J Adema
Apr 5, 2007·European Journal of Immunology·Giuseppe NocentiniCarlo Riccardi
May 10, 2007·Cancer Immunology, Immunotherapy : CII·Richard W GriffithsRobert E Hawkins
May 15, 2007·Proceedings of the National Academy of Sciences of the United States of America·Noriko Komatsu, Shohei Hori
May 16, 2007·The Journal of Experimental Medicine·Silvia DeaglioSimon C Robson
Jan 29, 2008·International Journal of Cancer. Journal International Du Cancer·Yoshiki MizukamiHideki Fujii
Oct 11, 2008·Science·Kajsa WingShimon Sakaguchi
Feb 4, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Hanne Krogh JensenHans von der Maase
Mar 10, 2009·Cell Biology International·Mengde CaoDavid Nelson
May 7, 2009·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Miroslaw J SzczepanskiMichael Boyiadzis
Aug 5, 2009·Proceedings of the National Academy of Sciences of the United States of America·Dat Q TranEthan M Shevach
Jan 20, 2010·Archives of Otolaryngology--head & Neck Surgery·Arie GordinVito Forte
Jan 26, 2010·Radiation Research·Yanyan QuYong Zhao

❮ Previous
Next ❯

Citations

Mar 11, 2016·Strahlentherapie und Onkologie : Organ der Deutschen Röntgengesellschaft ... [et al]·Peter Vaupel, Gabriele Multhoff
Mar 24, 2016·Nature Immunology·Jeremy G PriceMiriam Merad
Jun 14, 2018·PloS One·Ryosuke NakanoHideki Ohdan
Jul 22, 2016·The Cancer Journal·Eric D BrooksJames W Welsh
Nov 6, 2018·Oncoimmunology·Franziska EckertCécile Gouttefangeas
Jan 9, 2019·Frontiers in Immunology·Hanne LocySarah K Maenhout
Jul 3, 2019·International Journal of Molecular Sciences·Magdalena Jarosz-BiejNatalia Kułach
Jul 1, 2016·International Journal of Particle Therapy·Takashi ShimokawaTakashi Imai
Jul 23, 2020·Revista da Associação Médica Brasileira·Antonio Cassio Assis Pellizzon
Jun 7, 2018·Nature Reviews. Clinical Oncology·William L HwangJay S Loeffler
Nov 21, 2018·Frontiers in Immunology·Heike Kunze-SchumacherAndreas Krueger
Nov 8, 2018·Nature Reviews. Clinical Oncology·Eric D Brooks, Joe Y Chang
Aug 28, 2020·Frontiers in Immunology·Tiantian GuoZhengfei Zhu
Jan 18, 2017·Nature Reviews. Clinical Oncology·Ralph R WeichselbaumYang-Xin Fu
Jul 1, 2016·Personalized Medicine·Jella-Andrea AbrahamOlga Golubnitschaja
Jul 1, 2018·Military Medical Research·Jin-Song WangHai-Li Qian
Apr 2, 2019·Frontiers in Immunology·Franziska EckertStephan M Huber
Oct 23, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Christopher M JacksonCharles G Drake
Sep 22, 2019·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Mauricio S CaetanoJames W Welsh
Oct 26, 2018·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Zhen TaoBo Lu
Dec 10, 2020·Environment International·Katalin LumniczkyDörthe Schaue
May 24, 2021·International Journal of Radiation Oncology, Biology, Physics·Joseph SiaNicole M Haynes
May 28, 2021·Frontiers in Oncology·Jacob UklejaDavid T Miyamoto
Aug 30, 2019·International Immunopharmacology·Keywan MortezaeeBagher Farhood

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autophagy & Metabolism

Autophagy preserves the health of cells and tissues by replacing outdated and damaged cellular components with fresh ones. In starvation, it provides an internal source of nutrients for energy generation and, thus, survival. A powerful promoter of metabolic homeostasis at both the cellular and whole-animal level, autophagy prevents degenerative diseases. It does have a downside, however--cancer cells exploit it to survive in nutrient-poor tumors.

Cell Checkpoints & Regulators

Cell cycle checkpoints are a series of complex checkpoint mechanisms that detect DNA abnormalities and ensure that DNA replication and repair are complete before cell division. They are primarily regulated by cyclins, cyclin-dependent kinases, and the anaphase-promoting complex/cyclosome. Here is the latest research.

Apoptosis

Apoptosis is a specific process that leads to programmed cell death through the activation of an evolutionary conserved intracellular pathway leading to pathognomic cellular changes distinct from cellular necrosis

Carcinoma, Hepatocellular

Hepatocellular Carcinoma is a malignant cancer in liver epithelial cells. Discover the latest research on Hepatocellular Carcinoma here.

BCL-2 Family Proteins

BLC-2 family proteins are a group that share the same homologous BH domain. They play many different roles including pro-survival signals, mitochondria-mediated apoptosis and removal or damaged cells. They are often regulated by phosphorylation, affecting their catalytic activity. Here is the latest research on BCL-2 family proteins.

Autophagy & Model Organisms

Autophagy is a cellular process that allows degradation by the lysosome of cytoplasmic components such as proteins or organelles. Here is the latest research on autophagy & model organisms

Breast Cancer: BRCA1 & BRCA2

Mutations involving BRCA1, found on chromosome 17, and BRCA2, found on chromosome 13, increase the risk for specific cancers, such as breast cancer. Discover the last research on breast cancer BRCA1 and BRCA2 here.

Cancer Vaccines

Cancer vaccines are vaccines that either treat existing cancer or prevent development of a cancer.

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Apoptosis in Cancer

Apoptosis is an important mechanism in cancer. By evading apoptosis, tumors can continue to grow without regulation and metastasize systemically. Many therapies are evaluating the use of pro-apoptotic activation to eliminate cancer growth. Here is the latest research on apoptosis in cancer.

Autophagy & Disease

Autophagy is an important cellular process for normal physiology and both elevated and decreased levels of autophagy are associated with disease. Here is the latest research.

Carcinoma, Squamous Cell

Basal cell carcinoma is a form of malignant skin cancer found on the head and neck regions and has low rates of metastasis. Discover the latest research on basal cell carcinoma here.

Parkinson's Disease & Autophagy (MDS)

Autophagy leads to degradation of damaged proteins and organelles by the lysosome. Impaired autophagy has been implicated in several diseases. Here is the role of autophagy in Parkinson’s disease.

Breast Cancer: Therapeutic Approaches

Several different therapeutic approaches are used to treat breast cancer. These include chemotherapy, hormonal therapy, targeted therapy, and Immunotherapy. Discover the latest research on breast cancer therapeutic approaches here.

Breast Tumorigenesis

Breast tumorigenesis involves the production or formation of tumor(s) in breast tissue. Discover the latest research on breast tumorigenesis here.

Related Papers

Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
Esther M de KruijfPeter J K Kuppen
Inflammation Research : Official Journal of the European Histamine Research Society ... [et Al.]
Andrea BaloghKatalin Lumniczky
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
Manuel A SchmidtLuitpold V Distel
Archivum Immunologiae Et Therapiae Experimentalis
Lucas Cunha Dias de RezendeMarco Cesar Cunegundes Guimarães
© 2022 Meta ULC. All rights reserved